Denali regains full rights to brain therapy after Takeda ends partnership

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Denali regains full rights to brain therapy after Takeda ends partnership
(NASDAQ: DNLI) Delayed: 21.66 +0.64 (3.04%)
Previous Close $21.02    52 Week High $ 
Open $21.02    52 Week Low $ 
Day High $22.15    P/E N/A 
Day Low $20.92    EPS $ 
Volume 2,189,074